The Board of Directors of TAKE Solutions Limited has approved a proposal to change the company's name from "TAKE SOLUTIONS LIMITED" to "TAKE LIMITED", subject to member and regulatory approval. The decision was taken during a meeting held on Wednesday, May 13, 2026. The company has initiated a postal ballot process to seek shareholder consent for this name change, along with the appointment of a statutory auditor and amendments to the Memorandum of Association (MOA). The remote e-voting facility will be available from Monday, May 18, 2026, to Tuesday, June 16, 2026.

Key Resolutions

The postal ballot notice seeks member approval on four special businesses. The following table summarises the key resolutions:

Auditor Appointment and MOA Amendments

The board has appointed M/s. A. Raghavendra Rao & Associates, Chartered Accountants (FRN: 003324S, PRC No.: 018363), as Statutory Auditors to fill the casual vacancy caused by the resignation of M/s. Venkat and Rangaa LLP. The firm will hold office until the conclusion of the next Annual General Meeting in 2026.

Additionally, the board approved the adoption of a revised MOA to align with the Companies Act, 2013. This involves merging the existing Clause III(C) relating to "Other Objects" into Clause III(B), which pertains to Objects Incidental or Ancillary to the attainment of the Main Objects. The company also proposes to insert new object clauses to expand its business activities into healthcare technology, digital health solutions, diagnostics, pharmaceuticals, and biotechnology.

Postal Ballot and E-Voting Schedule

M/s. Hemang Satra & Associates, Practicing Company Secretaries (COP: 24235, PRC: 5684/2024), has been appointed as the Scrutinizer for the postal ballot process. The cut-off date for determining e-voting eligibility is Friday, May 08, 2026.

The Scrutinizer's Report will be announced within two working days from the conclusion of the e-voting process. Members can cast their votes through remote e-voting or via postal ballot forms. The results will be displayed on the company's website and the websites of the stock exchanges.

Take Solutions Limited has announced its strategic entry into India's longevity and anti-aging market through a comprehensive Regulation 30 filing dated April 17, 2026, marking a significant expansion into the healthcare and wellness sector.

Regulatory Filing Details

The company submitted formal notifications to both BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing outlined plans to disrupt the Indian longevity and anti-aging solutions market through science-backed nutraceuticals, biohacking solutions, and technology-enabled preventive healthcare offerings.

Market Opportunity and Growth Projections

The global longevity market presents substantial growth opportunities across multiple segments. The company aims to capitalize on India's growing health-conscious consumer base through its established expertise in clinical research and regulatory processes.

Strategic Business Model and Technology Integration

Take Solutions' entry strategy centers on a dual model combining product innovation with technology-enabled health solutions. The company plans to develop science-backed nutraceuticals, biohacking-focused products, and predictive digital tools for tracking metabolic health, sleep, cognition, and biological aging.

"Through this initiative, we aim to build a diversified revenue mix across consumer products, services, and digital platforms, while leveraging our core strengths in healthcare and regulatory execution to deliver solutions that are both scalable and clinically credible," said Mr. Parmeshvar Dhangare, Director of Take Solutions Limited.

Competitive Positioning and Market Strategy

The company believes its existing capabilities in healthcare operations, regulatory support, and life sciences can be extended to accelerate development, validation, and commercialization in the longevity market. This approach aims to create differentiated offerings in an underpenetrated market with strong repeat-purchase potential and attractive margin profiles, supported by rising consumer awareness and increasing lifestyle disease burden in India.